<!DOCTYPE html><html lang="en-us" >

<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 4.8.0">

  

  
  
  
  
  
  

  

  
  
  
    
  
  <meta name="description" content="DrugBank ID: db00133 DrugCentral: serine Synonymous :(s)-2-amino-3-hydroxypropanoic acid | (s)-serine | alpha-amino-beta-hydroxypropionic acid | beta-hydroxyalanine | l-serine | ser | serina | serine | serinum 
Drug Sentece Context Table 1.">

  
  <link rel="alternate" hreflang="en-us" href="https://bio-hub.github.io/platcovid/drugpanel/serine/info/">

  


  
  
  
  <meta name="theme-color" content="#2962ff">
  

  
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.0-1/css/all.min.css" integrity="sha256-4w9DunooKSr3MFXHXWyFER38WmPdm361bQS/2KUWZbU=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.css" integrity="sha256-Vzbj7sDDS/woiFS3uNKo8eIuni59rjyNGtXfstRzStA=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/styles/github.min.css" crossorigin="anonymous" title="hl-light">
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" disabled>
        
      
    

    

    

    
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/lazysizes/5.1.2/lazysizes.min.js" integrity="sha256-Md1qLToewPeKjfAHU1zyPwOutccPAm5tahnaw7Osw0A=" crossorigin="anonymous" async></script>
      
    
      

      
      

      
    
      

      
      

      
    
      

      
      
        
      

      
    
      

      
      

      
    

  

  
  
  
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Montserrat:400,700%7CRoboto:400,400italic,700%7CRoboto+Mono&display=swap">
  

  
  
  
  
  <link rel="stylesheet" href="/platcovid/css/academic.css">

  





<script async src="https://www.googletagmanager.com/gtag/js?id=UA-166873339-1"></script>
<script>
  window.dataLayer = window.dataLayer || [];

  function gtag() {
      dataLayer.push(arguments);
  }

  function trackOutboundLink(url, target) {
    gtag('event', 'click', {
         'event_category': 'outbound',
         'event_label': url,
         'transport_type': 'beacon',
         'event_callback': function () {
           if (target !== '_blank') {
             document.location = url;
           }
         }
    });
    console.debug("Outbound link clicked: " + url);
  }

  function onClickCallback(event) {
    if ((event.target.tagName !== 'A') || (event.target.host === window.location.host)) {
      return;
    }
    trackOutboundLink(event.target, event.target.getAttribute('target'));  
  }

  gtag('js', new Date());
  gtag('config', 'UA-166873339-1', {});

  
  document.addEventListener('click', onClickCallback, false);
</script>


  


  
  

  

  <link rel="manifest" href="/platcovid/index.webmanifest">
  <link rel="icon" type="image/png" href="/platcovid/images/icon_hu7e12209333f22d741aca7d462871821f_9877_32x32_fill_lanczos_center_2.png">
  <link rel="apple-touch-icon" type="image/png" href="/platcovid/images/icon_hu7e12209333f22d741aca7d462871821f_9877_192x192_fill_lanczos_center_2.png">

  <link rel="canonical" href="https://bio-hub.github.io/platcovid/drugpanel/serine/info/">

  
  
  
  
  
  
  
    
    
  
  
  <meta property="twitter:card" content="summary">
  
  <meta property="og:site_name" content="PlatCOVID">
  <meta property="og:url" content="https://bio-hub.github.io/platcovid/drugpanel/serine/info/">
  <meta property="og:title" content="SERINE | PlatCOVID">
  <meta property="og:description" content="DrugBank ID: db00133 DrugCentral: serine Synonymous :(s)-2-amino-3-hydroxypropanoic acid | (s)-serine | alpha-amino-beta-hydroxypropionic acid | beta-hydroxyalanine | l-serine | ser | serina | serine | serinum 
Drug Sentece Context Table 1."><meta property="og:image" content="https://bio-hub.github.io/platcovid/images/icon_hu7e12209333f22d741aca7d462871821f_9877_512x512_fill_lanczos_center_2.png">
  <meta property="twitter:image" content="https://bio-hub.github.io/platcovid/images/icon_hu7e12209333f22d741aca7d462871821f_9877_512x512_fill_lanczos_center_2.png"><meta property="og:locale" content="en-us">
  
    
      <meta property="article:published_time" content="2019-05-05T00:00:00&#43;01:00">
    
    <meta property="article:modified_time" content="2019-05-05T00:00:00&#43;01:00">
  

  



  


  


  





  <title>SERINE | PlatCOVID</title>

</head>

<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" >

  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search">
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


  







<nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
  <div class="container">

    
    <div class="d-none d-lg-inline-flex">
      <a class="navbar-brand" href="/platcovid/">PlatCOVID</a>
    </div>
    

    
    <button type="button" class="navbar-toggler" data-toggle="collapse"
            data-target="#navbar-content" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
    <span><i class="fas fa-bars"></i></span>
    </button>
    

    
    <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
      <a class="navbar-brand" href="/platcovid/">PlatCOVID</a>
    </div>
    

    
    
    <div class="navbar-collapse main-menu-item collapse justify-content-start" id="navbar-content">

      
      <ul class="navbar-nav d-md-inline-flex">
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/platcovid/syntax/"><span>Syntax</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/platcovid/genepanel/"><span>Gene Panel</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link  active" href="/platcovid/drugpanel/"><span>Drug Panel</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/platcovid/tissuepanel/"><span>Tissue Panel</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/platcovid/syntax_summary/"><span>Literature Consensus</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/platcovid/#about"><span>Contact</span></a>
        </li>

        
        

      

        
      </ul>
    </div>

    <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">
      
      <li class="nav-item">
        <a class="nav-link js-search" href="#"><i class="fas fa-search" aria-hidden="true"></i></a>
      </li>
      

      

      

    </ul>

  </div>
</nav>


  <article class="article">

  












  

  
  
  
<div class="article-container pt-3">
  <p style="font-size:25px" align="justify">SERINE</p>

  

  
    


<div class="article-metadata">

  
  

  

  

  

  
  
  

  
  

</div>

    














  
</div>



  <div class="article-container">

    <div class="article-style">
      
<script src="/rmarkdown-libs/kePrint/kePrint.js"></script>
<link href="/rmarkdown-libs/lightable/lightable.css" rel="stylesheet" />


<hr />
<p align="left" style="font-size:16px">
DrugBank ID: <a href='https://www.drugbank.ca/drugs/db00133' target='_blank'>db00133</a> <br>
DrugCentral: <a href="http://drugcentral.org/?q=serine" target="_blank">serine</a> <br>
Synonymous :(s)-2-amino-3-hydroxypropanoic acid | (s)-serine | alpha-amino-beta-hydroxypropionic acid | beta-hydroxyalanine | l-serine | ser | serina | serine | serinum
</p>
<p><br></p>
<hr />
<div id="drug-sentece-context" class="section level2">
<h2>Drug Sentece Context</h2>
<br>
<p style="font-size:12px" align="center">
<strong>Table 1.</strong> Analysis of context sentence of <em>serine</em> gene in 302 abstracts.
</p>
<table class="table table-striped" style="width: auto !important; margin-left: auto; margin-right: auto;">
<thead>
<tr>
<th style="text-align:center;position: sticky; top:0; background-color: #FFFFFF;">
pmid
</th>
<th style="text-align:center;position: sticky; top:0; background-color: #FFFFFF;">
sentence
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:center;">
<a href="/publication/32027036" target="_blank">32027036</a>
</td>
<td style="text-align:center;">
Despite the low heterogeneity of the 2019-nCoV genomes, we could identify at least two hypervariable genomic hotspots, one of which is responsible for a Serine/Leucine variation in the viral ORF8-encoded protein.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32083328" target="_blank">32083328</a>
</td>
<td style="text-align:center;">
Position 723 in the COVID-2019 has a serine instead a glycine residue, while at aminoacidic position 1010 a proline instead an isoleucine.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32142651" target="_blank">32142651</a>
</td>
<td style="text-align:center;">
Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32271454" target="_blank">32271454</a>
</td>
<td style="text-align:center;">
The protein-protein interaction network exhibited hub targets of MXSGD, such as Heat shock protein 90, RAC-alpha serine/threonine-protein kinase, Transcription factor AP-1, Mitogen-activated protein kinase 1, Cellular tumor antigen p53, Vascular endothelial growth factor A, and Tumour necrosis factor.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32278065" target="_blank">32278065</a>
</td>
<td style="text-align:center;">
SARS-CoV uses the the angiotensin-converting enzyme 2 (ACE2) and the serine protease TMPRSS2 for S protein priming.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32279064" target="_blank">32279064</a>
</td>
<td style="text-align:center;">
Similar to the respiratory mucosa, angiotensin converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 TMPRSS2) co-express in the gastrointestinal tract, which facilitates viral entry into the tissue.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32299776" target="_blank">32299776</a>
</td>
<td style="text-align:center;">
These pulmonary findings were accompanied by significant deposits of terminal complement components C5b-9 (membrane attack complex), C4d, and mannose binding lectin (MBL)-associated serine protease (MASP)2, in the microvasculature, consistent with sustained, systemic activation of the alternative and lectin-based complement pathways.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32316719" target="_blank">32316719</a>
</td>
<td style="text-align:center;">
<b>Objective:</b> Angiotensin converting enzyme 2 (ACE2) and Transmembrane serine protease 2 (TMPRSS2) are the key proteins for 2019-nCoV entry into host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32321878" target="_blank">32321878</a>
</td>
<td style="text-align:center;">
This serine/threonine protein kinase is now recognised as a point of convergence for host inflammatory response.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32325025" target="_blank">32325025</a>
</td>
<td style="text-align:center;">
(Cell) identify ACE2 as a SARS-CoV-2 receptor, and the latter show its entry mechanism depends on cellular serine protease TMPRSS2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32331255" target="_blank">32331255</a>
</td>
<td style="text-align:center;">
The interaction of the SARS-CoV-2 spike protein with the human ACE2 (angiotensin-converting enzyme 2) receptor, and its subsequent cleavage by serine protease and fusion, are the main events in the pathophysiology. […] The serine protease inhibitors, spike protein-based vaccines, or ACE2 blockers may have therapeutic potential in the near future.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32333601" target="_blank">32333601</a>
</td>
<td style="text-align:center;">
We hypothesized that the viral entry molecules angiotensin I converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) are expressed in the intestine.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32335456" target="_blank">32335456</a>
</td>
<td style="text-align:center;">
While the binding to host cell receptor is the first step of infection, the entrance of the virus into the cell needs the cleavage of S1-S2 subunits to expose S2 for fusion to cell membrane via host proteases including cathepsins, cell surface transmembrane protease/serine (TMPRSS) proteases, furin, trypsin and factor Xa.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32336007" target="_blank">32336007</a>
</td>
<td style="text-align:center;">
Dipeptidyl peptidase 4 (DPP4), also known as cluster of differentiation 26 (CD26), is a serine exopeptidase expressed ubiquitously in several tissues, including but not limited to lung, kidney, liver, gut, and immune cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32343593" target="_blank">32343593</a>
</td>
<td style="text-align:center;">
Finally, the small bowel is rich in furin, a serine protease which can separate the S-spike of the coronavirus into two “pinchers” (S1 and 2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32343658" target="_blank">32343658</a>
</td>
<td style="text-align:center;">
Transmembrane protease serine 2 (TMPRSS2) plays a role in the fusion of the virus with cells; inhibitors of this enzyme are known as well.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32345328" target="_blank">32345328</a>
</td>
<td style="text-align:center;">
In this study, we investigated the gene expression of angiotensin I-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) with prognosis in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32348692" target="_blank">32348692</a>
</td>
<td style="text-align:center;">
Angiotensin converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) mediate viral infection of host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32352535" target="_blank">32352535</a>
</td>
<td style="text-align:center;">
Mechanistically, SARS-CoV-2, following proteolytic cleavage of its S protein by a serine protease, binds to the transmembrane angiotensin-converting enzyme 2 (ACE2) -a homologue of ACE-to enter type 2 pneumocytes, macrophages, perivascular pericytes, and cardiomyocytes.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32352944" target="_blank">32352944</a>
</td>
<td style="text-align:center;">
S-proteins covering its surface, which bind to the cell receptor - angiotensin converting enzyme 2 (ACE-2) and transmembrane serine protease (TMPRSS2) are important in shaping virus activity.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32360480" target="_blank">32360480</a>
</td>
<td style="text-align:center;">
Such drugs comprise inhibitors of TMPRSS2 serine protease and inhibitors of angiotensin-converting enzyme 2 (ACE2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32376402" target="_blank">32376402</a>
</td>
<td style="text-align:center;">
Among them, Mitogen-activated protein kinase kinase (MEK), serine-threonine kinase (AKT), mammalian target of rapamycin (mTOR) and I kappa B Kinase (IKK) inhibitors emerged as candidate drugs.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32376714" target="_blank">32376714</a>
</td>
<td style="text-align:center;">
Cleavage of the spike protein by transmembrane protease serine 2 and other cellular proteases initiates fusion and endocytosis.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32376987" target="_blank">32376987</a>
</td>
<td style="text-align:center;">
The transmembrane serine protease TMPRSS2 was previously identified as the essential protease that can cleave hemagglutinin of many subtypes of influenza virus and spike protein of coronavirus.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32382146" target="_blank">32382146</a>
</td>
<td style="text-align:center;">
To determine the expressions of SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) and type II transmembrane serine protease (TMPRSS2) genes in human and mouse ocular cells and comparison to other tissue cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32404436" target="_blank">32404436</a>
</td>
<td style="text-align:center;">
Expression of two mucosa-specific serine proteases, TMPRSS2 and TMPRSS4, facilitated SARS-CoV-2 spike fusogenic activity and promoted virus entry into host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32408547" target="_blank">32408547</a>
</td>
<td style="text-align:center;">
In the current study, we used an in silico approach to screen natural compounds to find potent inhibitors of the host enzyme transmembrane protease serine 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32410502" target="_blank">32410502</a>
</td>
<td style="text-align:center;">
TMPRSS2 encodes a transmembrane serine protease which plays a crucial role in SARS-CoV-2 cell entry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32412125" target="_blank">32412125</a>
</td>
<td style="text-align:center;">
The androgen receptor regulates transcription of the transmembrane protease, serine 2 (TMPRSS2), which is required for SARS-CoV-2 infectivity.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32412310" target="_blank">32412310</a>
</td>
<td style="text-align:center;">
Prostate cancer is one of the most common cancers among men and raises particular interest during the pandemic as recent reports show that the TMPRSS2 (and other serine proteases), which facilitate the entry, replication and budding of the virion from a cell, can be inhibited using androgen deprivation therapy.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32413319" target="_blank">32413319</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 spike (S) protein binds angiotensin-converting enzyme 2 (ACE2), and in concert with host proteases, principally transmembrane serine protease 2 (TMPRSS2), promotes cellular entry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32422146" target="_blank">32422146</a>
</td>
<td style="text-align:center;">
To extend our work in interleukin (IL)-13 biology to determine if airway epithelial cell expression of two key mediators critical for SARS-CoV-2 infection, angiotensin-converting enzyme 2 (ACE2) and transmembrane protease, serine 2 (TMPRSS2) are modulated by IL-13.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32423094" target="_blank">32423094</a>
</td>
<td style="text-align:center;">
Firstly, SARS-CoV-2 has a strong interaction with the human ACE2 receptor, which plays an essential role in cell entry together with transmembrane serine protease 2 (TMPRSS2); it is interesting to note that the <i>ACE2</i> gene lays on the X-chromosome, thus allowing females to be potentially heterozygous and differently assorted compared to men who are definitely hemizygous.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32452644" target="_blank">32452644</a>
</td>
<td style="text-align:center;">
The key steps of virus life cycle have been recently clarified, highlighting the role of host type 2 angiotensin converting enzyme (ACE2) and TMPRSS2 serine protease in virus-cell binding and entry, respectively.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32455942" target="_blank">32455942</a>
</td>
<td style="text-align:center;">
Processing of certain viral proteins and bacterial toxins by host serine proteases is a frequent and critical step in virulence. […] However, there remains some confusion on the relative roles of the possible serine proteases involved for priming. […] Using anthrax toxin as a model system, we show that in vivo inhibition of priming by pan-active serine protease inhibitors can be effective at suppressing toxicity. […] Hence, our studies should encourage further efforts in developing either pan-serine protease inhibitors or inhibitor cocktails to target SARS-CoV2 and potentially ward off future pandemics that could develop because of additional mutations in the S-protein priming sequence in coronaviruses.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32468052" target="_blank">32468052</a>
</td>
<td style="text-align:center;">
SARS‑CoV‑2 infection of host cells is facilitated by the angiotensin‑converting enzyme 2 (ACE‑2), and by transmembrane protease serine 2 (TMPRSS2) and other host cell proteases such as cathepsin L (CTSL).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32469279" target="_blank">32469279</a>
</td>
<td style="text-align:center;">
Here, we used a homology-based structural model of transmembrane protease serine 2 (TMPRSS2), a cell surface receptor, required for entry of virus to the target host cell.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32470470" target="_blank">32470470</a>
</td>
<td style="text-align:center;">
We provide evidence that supports the combined use of serine protease and CatL inhibitors as a possibly safer and more effective therapy than other available therapeutics to block coronavirus host cell entry and intracellular replication, without compromising the immune system.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32482249" target="_blank">32482249</a>
</td>
<td style="text-align:center;">
To describe detection of severe acute respiratory syndrome (SARS)-coronavirus 2 (CoV-2) in seminal fluid of patients recovering from coronavirus disease 2019 (COVID-19) and to describe the expression profile of angiotensin-converting enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) within the testicle.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32488318" target="_blank">32488318</a>
</td>
<td style="text-align:center;">
These lesions may be associated with multisystemic manifestations that could occur due to angiotensin-converting enzyme 2 receptor and transmembrane serine protease action, allowing the pulmonary infection and possibly skin manifestation.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32491949" target="_blank">32491949</a>
</td>
<td style="text-align:center;">
Specifically, decreased expression of proteins, including angiotensin-converting enzyme 2 (<i>ACE2</i>) and Transmembrane Serine Protease 2 (<i>TMPRSS2</i>) in the airway epithelium in children may prevent viral entry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32492203" target="_blank">32492203</a>
</td>
<td style="text-align:center;">
Genetic confirmation of the hypotheses regarding gene expression and mutation pattern of target genes, including angiotensin-converting enzyme-2 (ACE2), transmembrane serine protease 2 (TMPRSS2), basigin (CD147/BSG) and paired basic amino acid cleaving enzyme (FURIN/PCSK3), as well as correlation analysis, was done in relation to lung adenocarcinoma (LUAD) and lung squamous carcinoma (LUSC) using in silico analysis.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32493627" target="_blank">32493627</a>
</td>
<td style="text-align:center;">
The presence of glutamine, asparagine, leucine, phenylalanine and serine amino acids in SARS-CoV-2 enhances ACE2 binding. […] The N protein is composed of a serine-rich linker region sandwiched between N Terminal Domain (NTD) and C Terminal Domain (CTD).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32497257" target="_blank">32497257</a>
</td>
<td style="text-align:center;">
In the attempt to understand how the virus spreads and how to pharmacologically abolish it, it was highlighted that SARS-CoV-2 infects human cells by means of angiotensin converting enzyme 2 (ACE2), transmembrane protease serine 2 (TMPRSS2) and SARS-CoV-2 main protease (M<sup>pro</sup> ).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32508311" target="_blank">32508311</a>
</td>
<td style="text-align:center;">
Early reports have confirmed that transmembrane serine protease 2 (TMPRSS2) and angiotensin converting enzyme 2 (ACE2) are critical targets of SARS-CoV-2 that facilitate viral entry into host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32512290" target="_blank">32512290</a>
</td>
<td style="text-align:center;">
Subsequently, the S protein is cleaved by transmembrane protease serine 2 with the help of FURIN which facilitates the entry of the virus into the cell after binding.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32524732" target="_blank">32524732</a>
</td>
<td style="text-align:center;">
T, co-regulating the expression of angiotensin-converting enzyme 2 and transmembrane protease serine 2 in host cells, may facilitate SARS-CoV-2 internalization.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32532094" target="_blank">32532094</a>
</td>
<td style="text-align:center;">
We previously found that nafamostat mesylate, an existing drug used for disseminated intravascular coagulation (DIC), effectively blocked Middle East respiratory syndrome coronavirus (MERS-CoV) S protein-mediated cell fusion by targeting transmembrane serine protease 2 (TMPRSS2), and inhibited MERS-CoV infection of human lung epithelium-derived Calu-3 cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32537478" target="_blank">32537478</a>
</td>
<td style="text-align:center;">
It has been reported that angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) are the main cell entry proteins for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and play a critical role in causing coronavirus disease 2019 (COVID-19).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32538775" target="_blank">32538775</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 has to use nuclear factor-κB (NF-kB), caveloae, clathrin, lipoxin, serine protease and proteasome pathways in addition to ACE2 to enter the target cell and initiate damage.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32546188" target="_blank">32546188</a>
</td>
<td style="text-align:center;">
Ongoing trials directly and indirectly target COVID-19-related endothelial dysfunctions: i.e., a virus-cell entry using recombinant angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS-2) blockade, coagulation activation, and immunomodulatory therapies, such as anti-IL-6 strategies.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32555974" target="_blank">32555974</a>
</td>
<td style="text-align:center;">
Studies carried out to date on possible SARS-CoV2 drug targets highlight glycoprotein S, Mpro (main protease or protease type 3C), and a member of the transmembrane serine protease II families (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32562397" target="_blank">32562397</a>
</td>
<td style="text-align:center;">
Similar to the respiratory mucosa, angiotensin converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 (TMPRSS2) co-express in the gastrointestinal tract, which facilitates viral entry into the tissue.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32572552" target="_blank">32572552</a>
</td>
<td style="text-align:center;">
The current body of evidence indicates that SARS-CoV‑2 requires the membrane-bound angiotensin-converting enzyme 2 (ACE2) and the membrane-bound serine protease TMPRSS2 to enter cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32574109" target="_blank">32574109</a>
</td>
<td style="text-align:center;">
Specifically, we review the potential clinical utility of two transmembrane serine protease 2 (TMPRSS2)-targeting protease inhibitors, nafamostat mesylate and camostat mesylate, as well as two novel potent fusion inhibitors and the repurposed Ebola drug, remdesivir, which is specific to RdRp, against human coronaviruses, including SARS-CoV-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32574265" target="_blank">32574265</a>
</td>
<td style="text-align:center;">
These drugs include therapeutics with potential to inhibit SARS-CoV-2 entry into host cells such as serine protease inhibitors of the cellular protease TMPS2 and drugs targeting the renin-angiotensin system; antivirals with potential to block SARS-CoV-2 replication or factors that could boost the antiviral response; monoclonal antibodies targeting pro-inflammatory cytokines that drive the hyperinflammatory response during COVID-19 progression toward the severe stage and therapeutics that could ameliorate the function of the lungs.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32574272" target="_blank">32574272</a>
</td>
<td style="text-align:center;">
Host proteases, e.g., cathepsins, furin, or members of the type II transmembrane serine proteases (TTSP) family, such as Transmembrane protease serine 2 (TMPRSS2), are involved in virus entry by proteolytically activating virus ligands.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32574273" target="_blank">32574273</a>
</td>
<td style="text-align:center;">
Finally, a direct effect of GL or GA to reduce virus transmission exists, which may involve reduced expression of type 2 transmembrane serine protease (TMPRSS2), which is required for virus uptake.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32582302" target="_blank">32582302</a>
</td>
<td style="text-align:center;">
The SARS-CoV-2 virus responsible for the infection depends on two human genes: the human receptor angiotensin converting enzyme 2 (<i>ACE2</i>) for cell invasion, and the serine protease <i>TMPRSS2</i> for S protein priming.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32583042" target="_blank">32583042</a>
</td>
<td style="text-align:center;">
At the time of the research, angiotensin-converting enzyme 2 (ACE2) was clearly identified as the receptor and transmembrane serine protease 2 (TMPRSS2) as the necessary protease to enable the infection of human cells with SARS-CoV‑2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32587094" target="_blank">32587094</a>
</td>
<td style="text-align:center;">
Using this quantitative matrix, we elucidated 47 potential functional missense variants from genomic databases within ACE2/SLC6A19/transmembrane serine protease 2 (TMPRSS2), warranting genomic enrichment analyses in SARS-CoV-2 patients.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32589459" target="_blank">32589459</a>
</td>
<td style="text-align:center;">
The spike proteins of SARS-CoV-2 interact with ACE2 or basigin/CD147 receptors, regulating human-to-human transmissions of COVID-19 together with serine protease TMPRSS2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32595355" target="_blank">32595355</a>
</td>
<td style="text-align:center;">
One of the important SARS-CoV-2 targets namely type 2 transmembrane serine protease (TMPRSS2) was screened with NPC’s NIH small molecule library which includes approved drugs by FDA and compounds in clinical investigation.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32595360" target="_blank">32595360</a>
</td>
<td style="text-align:center;">
The aim of this study was to investigate the molecular interactions between monoterpenoids and spike protein of 2019-nCoV together with the cellular proteases [transmembrane serine protease 2 (TMPRSS2), cathepsin B (CatB), and cathepsin L (CatL)].
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32619328" target="_blank">32619328</a>
</td>
<td style="text-align:center;">
To illustrate the incidence of criteria (lupus anticoagulant [LAC], anticardiolipin [aCL] immunoglobulin G [IgG]/IgM, antibeta2-glycoprotein I antibodies [aβ2GPI] IgG/IgM) and noncriteria (anti-phosphatidyl serine/prothrombin [aPS/PT], aCL, and aβ2GPI IgA) aPL in a consecutive cohort of critically ill SARS-CoV-2 patients, their association with thrombosis, antibody profile and titers of aPL.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32620366" target="_blank">32620366</a>
</td>
<td style="text-align:center;">
The aim of this brief communication is to describe the pathophysiology of this sex-discrepancy, based on the infectivity mechanism of the coronavirus including the Angiotensin-Converting Enzyme 2 (ACE2), the Type II transmembrane Serine Protease (TMPRSS2), and the androgen receptor.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32622411" target="_blank">32622411</a>
</td>
<td style="text-align:center;">
Identification of cell types coexpressing the key angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) genes and proteins as well as other candidates potentially involved in SARS-CoV-2 cell entry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32624257" target="_blank">32624257</a>
</td>
<td style="text-align:center;">
Binding requires the help of another host protein, transmembrane protease serine S1 member 2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32633815" target="_blank">32633815</a>
</td>
<td style="text-align:center;">
Only serine (Ser) in pangolin and both threonine (Thr) and serine (Ser) O-linked glycans were seen in RaTG13, suggesting that a detailed study needed in pangolin (Manis javanica) and bat (Rhinolophus affinis) related CoV.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32638018" target="_blank">32638018</a>
</td>
<td style="text-align:center;">
Inversely, the most important S protein cleavage protease TMPRSS2 (transmembrane protease serine protease-2) in the heart exhibits an extremely lower expression than that in the lung (adjusted P &lt; 0.0001), which may restrict entry of SARS-CoV-2 into cardiac cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32639031" target="_blank">32639031</a>
</td>
<td style="text-align:center;">
Activation of proteinase-activated receptor 1 (PAR1), in particular by the serine protease thrombin, is a critical element in platelet aggregation and coagulation.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32641482" target="_blank">32641482</a>
</td>
<td style="text-align:center;">
Interestingly, overexpression of serine protease TMPRSS2 or amphotericin treatment significantly neutralized the IFN-inducible transmembrane 3 (IFITM3) restriction of human coronavirus (CoV) entry, but did not compromise the effect of LY6E on the entry of human coronaviruses.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32661206" target="_blank">32661206</a>
</td>
<td style="text-align:center;">
Cellular receptor ACE2, serine protease TMPRSS2 and exopeptidase CD26 (also known as DPP4) are the three membrane bound proteins potentially implicated in SARS-CoV-2 infection.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32662421" target="_blank">32662421</a>
</td>
<td style="text-align:center;">
The novel coronavirus canonically utilizes the angiotensin-converting enzyme 2 (ACE2) receptor and the serine protease TMPRSS2 for cell entry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32664949" target="_blank">32664949</a>
</td>
<td style="text-align:center;">
It is cleaved by type II transmembrane serine protease (TMPRSS)2 and disintegrin and metallopeptidase domain (ADAM)17 to assist viral entry into host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32668165" target="_blank">32668165</a>
</td>
<td style="text-align:center;">
Second, mRNA for ACE2 is elevated and mRNA for TMPRSS2, a serine protease, is decreased in CF airway epithelial cells. […] Second, many CF patients are treated with azithromycin, which suppresses viral infection and lung inflammation and inhibits the activity of furin, a serine protease. […] Finally, the CF lung contains high levels of serine protease inhibitors including ecotin and SERPINB1, which are predicted to reduce the ability of TMPRSS2 to facilitate SARS-CoV-2 entry into airway epithelial cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32672528" target="_blank">32672528</a>
</td>
<td style="text-align:center;">
Transmembrane serine protease 2 (TMPRSS2) has been established as one of the host proteins that facilitate entry of coronaviruses into host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32675206" target="_blank">32675206</a>
</td>
<td style="text-align:center;">
SARS-CoV, the agent responsible for the 2003 SARS outbreak, utilises angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) host molecules for viral entry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32675285" target="_blank">32675285</a>
</td>
<td style="text-align:center;">
Type II transmembrane serine proteases (TTSPs) are a group of enzymes participating in diverse biological processes.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32686577" target="_blank">32686577</a>
</td>
<td style="text-align:center;">
Structural analyses have elucidated hot spots in viral binding domains, mutations, and specific proteins in the host such as the receptor angiotensin-converting enzyme 2 (ACE2) and the transmembrane protease serine 2 (TMPRSS2) to be implicated in cell entry and viral infectivity.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32687449" target="_blank">32687449</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 relies on 2 host cell receptors for successful attachment: angiotensin-converting enzyme 2 and transmembrane protease serine 2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32690544" target="_blank">32690544</a>
</td>
<td style="text-align:center;">
The coronaviral entry requires the spike (S)-protein for attachment to the host cell surface, and employs human angiotensin-converting enzyme 2 (hACE2) for entry and transmembrane protease serine 2 (TMPRSS2) for S-protein priming.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32692176" target="_blank">32692176</a>
</td>
<td style="text-align:center;">
Cathepsin C (CatC) is a cysteine dipeptidyl aminopeptidase that activates most of tissue-degrading elastase-related serine proteases.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32695123" target="_blank">32695123</a>
</td>
<td style="text-align:center;">
Firstly, it is already clear that GSK-3 phosphorylation of SARs CoV1 N protein on key serine residues is needed for viral replication such that small molecule inhibitors (SMIs) of GSK-3 can inhibit viral replication.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32703421" target="_blank">32703421</a>
</td>
<td style="text-align:center;">
Following receptor binding, transmembrane protease serine 2 (encoded by TMPRSS2) primes the S protein to allow cellular uptake.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32703818" target="_blank">32703818</a>
</td>
<td style="text-align:center;">
In the present study, we show that S can be cleaved by the proprotein convertase furin at the S1/S2 site and the transmembrane serine protease 2 (TMPRSS2) at the S2’ site. […] Combining various TMPRSS2 inhibitors with furin inhibitor MI-1851 produced more potent antiviral activity against SARS-CoV-2 than an equimolar amount of any single serine protease inhibitor.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32718020" target="_blank">32718020</a>
</td>
<td style="text-align:center;">
Frequent targets are the viral spike protein, the host angiotensin converting enzyme 2, the host transmembrane protease serine 2, and clathrin-mediated endocytosis process.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32721806" target="_blank">32721806</a>
</td>
<td style="text-align:center;">
Angiotensin-converting enzyme-2 (ACE2) receptor, regulation of the renin-angiotensin-aldosterone system (RAAS), and transmembrane serine protease 2 (TMPRSS2) action are critical for the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) cell entry and infectivity.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32726128" target="_blank">32726128</a>
</td>
<td style="text-align:center;">
Testosterone on the contrary enhances the levels of the two most critical molecules, angiotensin-converting enzyme 2 (ACE2) and the transmembrane protease serine-type 2 (TMPRSS2), transcriptionally and posttranslationally, thereby increasing viral load and delaying viral clearance in men as compared with women.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32726325" target="_blank">32726325</a>
</td>
<td style="text-align:center;">
Development of novel approaches for regulating the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) is becoming increasingly important within the context of the ongoing COVID-19 pandemic since these enzymes play a crucial role in cell infection.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32730844" target="_blank">32730844</a>
</td>
<td style="text-align:center;">
A putative target to interfere with the virus is the host transmembrane serine protease family member II (TMPRSS2). […] Repositioning approved, investigational and experimental drugs on the serine protease domain of TMPRSS2 could thus be valuable. […] There is no experimental structure for TMPRSS2 but it is possible to develop quality structural models for the serine protease domain using comparative modeling strategies as such domains are highly structurally conserved.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32741259" target="_blank">32741259</a>
</td>
<td style="text-align:center;">
SARS-CoV and SARS-CoV-2 employ the host cellular serine protease TMPRSS2 for spike (S) protein priming for viral entry into host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32748331" target="_blank">32748331</a>
</td>
<td style="text-align:center;">
It has been reported that SARS-CoV-2 enters into the host cell through interaction between conserved residues of viral spike protein and angiotensin converting enzyme 2 (ACE2) receptor which is highly expressed in host’s cardiac and pulmonary cells and finally transmembrane protease, serine-2 (TMPRSS2), helps in priming of the surface protein.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32755524" target="_blank">32755524</a>
</td>
<td style="text-align:center;">
SARS-CoV-2, which is an enveloped, RNA virus has been shown to attach to the host cell receptor angiotensin converting enzyme 2 with spike (S) protein and membrane fusion is provided by transmembrane protease serine 2 (TMPRSS2) of the host cell.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32757420" target="_blank">32757420</a>
</td>
<td style="text-align:center;">
We therefore performed data mining of two independent NCBI GEO genome-wide RNA expression files (GSE7894 and GSE994) and report that in both data sets, current smokers and never smokers have, on average, closely similar bronchial epithelial cell mRNA levels of ACE2, as well as TMPRSS2, coding for a serine protease priming SARS-Cov-2 for cell entry, and ADAM17, coding for a protease implicated in ACE2 membrane shedding.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32759995" target="_blank">32759995</a>
</td>
<td style="text-align:center;">
The entry of SARS-CoV-2 into host cells is dependent upon angiotensin-converting enzyme 2 (ACE2), which serves as a functional attachment receptor for the viral spike glycoprotein, and the serine protease TMPRSS2 which allows fusion of the viral and host cell membranes.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32763970" target="_blank">32763970</a>
</td>
<td style="text-align:center;">
Deleting NLRP3 inflammasome components or the downstream cell death executioner gasdermin D (GSDMD) led to an initial reduction in cell death followed by a robust increase in the incidence of caspase-8- and receptor-interacting serine/threonine-protein kinase 3 (RIPK3)-mediated inflammatory cell deathafter coronavirus infection.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32764454" target="_blank">32764454</a>
</td>
<td style="text-align:center;">
On the other hand, it has been reported that SARS-CoV-2 spike (S) protein binds to angiotensin-converting enzyme 2 (ACE-2), that promotes cellular entry of this virus in concert with host proteases, principally transmembrane serine protease 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32768580" target="_blank">32768580</a>
</td>
<td style="text-align:center;">
This study investigates the N720D variant, positioned in the collectrin-like domain (CLD) at proximity to type II transmembrane serine protease (TMPRSS2) cleavage site.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32769760" target="_blank">32769760</a>
</td>
<td style="text-align:center;">
Based on these intricate mechanisms, various preventive and therapeutic strategies may be devised, such as upregulating ACE2 and/or using recombinant ACE2, and exploiting the NEP, bradykinin and serine protease pathways, in addition to anti-inflammatory and antiviral therapies.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32783758" target="_blank">32783758</a>
</td>
<td style="text-align:center;">
It illustrates new analyses of the structure of ACE2 that provides better understanding of its actions particularly in lung and gut, shedding of ACE2 by ADAM17 (a disintegrin and metallopeptidase domain 17 protein), and role of TMPRSS2 (transmembrane serine proteases 2) in severe acute respiratory syndrome coronavirus-2 entry into host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32786691" target="_blank">32786691</a>
</td>
<td style="text-align:center;">
As a function of IL-6 levels, we identified significant dysregulation in serum levels of various coagulation factors, accompanied by increased levels of antifibrinolytic components, including several serine protease inhibitors (SERPINs).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32808185" target="_blank">32808185</a>
</td>
<td style="text-align:center;">
Angiotensin-converting enzyme 2 (ACE2) and Transmembrane serine protease (TMPRSS2) are the main cell entry receptors of SARS-CoV-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32810867" target="_blank">32810867</a>
</td>
<td style="text-align:center;">
Recent research has confirmed the role of angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) as key host-specific cellular moieties responsible for the cellular entry of the virus.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32816230" target="_blank">32816230</a>
</td>
<td style="text-align:center;">
To review the data regarding the expression of angiotensin converting enzyme-2 (ACE2) and transmembrane protease serine-2 (TMPRSS2) in head and neck tissue.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32824674" target="_blank">32824674</a>
</td>
<td style="text-align:center;">
High testosterone levels could upregulate transmembrane serine protease 2 (TMPRSS2), facilitating the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into host cells via angiotensin-converting enzyme 2 (ACE2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32825469" target="_blank">32825469</a>
</td>
<td style="text-align:center;">
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor, angiotensin-converting enzyme 2 (ACE2), transmembrane protease serine 2 (TMPRSS2), and furin, which promote entry of the virus into the host cell, have been identified as determinants of SARS-CoV-2 infection.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32826650" target="_blank">32826650</a>
</td>
<td style="text-align:center;">
Using immunohistochemistry, the samples were tested for the expression of angiotension-converting enzyme 2 (ACE2), dendritic cell-specific intracellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN), DC-SIGN-related protein (DC-SIGNR), and transmembrane serine protease 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32829149" target="_blank">32829149</a>
</td>
<td style="text-align:center;">
We highlight 376 approved, investigational or experimental drugs targeting S1A serine proteases that may also inhibit TMPRSS2. […] Whilst the presence of a relatively uncommon lysine residue in the S2/S3 subsites means that some serine protease inhibitors will not inhibit TMPRSS2, this residue is likely to provide a handle for selective targeting in a focused drug discovery project. […] We discuss how experimental drugs targeting related serine proteases might be repurposed as TMPRSS2 inhibitors to treat coronaviruses.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32835132" target="_blank">32835132</a>
</td>
<td style="text-align:center;">
mTOR is a serine-threonine kinase and participates in cell proliferation, cellular metabolism was found to be activated during Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection and replication.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32837754" target="_blank">32837754</a>
</td>
<td style="text-align:center;">
In order to investigate the potential risk of SARS-CoV-2 vertical transmission, we explored ACE2 and transmembrane protease serine 2 (TMPRSS2) expression patterns in peri-implantation embryos and the maternal-fetal interface using previously published single-cell transcriptome data.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32844538" target="_blank">32844538</a>
</td>
<td style="text-align:center;">
A1AT inhibits SARS-CoV-2 infection and two of the most important proteases in the pathophysiology of Covid-19: the transmembrane serine protease 2 (TMPRSS2) and the disintegrin and metalloproteinase 17 (ADAM17).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32848790" target="_blank">32848790</a>
</td>
<td style="text-align:center;">
Interestingly, some products may block the ACE-2 receptor or the serine protease TMPRRS2 required by SARS-CoV-2 to infect human cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32851855" target="_blank">32851855</a>
</td>
<td style="text-align:center;">
ACE2 expression in the lungs is relatively low, but it is present in type II pneumocytes-a cell type also endowed with TMPRSS2 (transmembrane protease serine 2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32853537" target="_blank">32853537</a>
</td>
<td style="text-align:center;">
Although there is some evidence that severe acute respiratory syndrome coronavirus 2 can invade the human placenta, limited data exist on the gestational age-dependent expression profile of the severe acute respiratory syndrome coronavirus 2 cell entry mediators, angiotensin-converting enzyme 2 and transmembrane protease serine 2, at the human maternal-fetal interface. […] This is important because the expression of decidual and placental angiotensin-converting enzyme 2 and transmembrane protease serine 2 across gestation may affect the susceptibility of pregnancies to vertical transmission of severe acute respiratory syndrome coronavirus 2. […] This study aimed to investigate the expression pattern of specific severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across human pregnancy and in paired samples of decidua and placenta in pregnancies complicated by preterm birth or preeclampsia compared with those in term uncomplicated pregnancies. […] Samples were subjected to quantitative polymerase chain reaction and next-generation sequencing or RNA sequencing for next-generation RNA sequencing for angiotensin-converting enzyme 2 and transmembrane protease serine 2 mRNA expression quantification, respectively. […] In the first cohort, angiotensin-converting enzyme 2 and transmembrane protease serine 2, exhibited a gestational age-dependent expression profile, that is, angiotensin-converting enzyme 2 and transmembrane protease serine 2 mRNA was higher (P&lt;.05 in the first-trimester placenta than second-trimester preterm birth and term placentae exhibited a negative correlation with gestational age contrast transmembrane protease serine was expressed both decidual placental samples but did not change pregnancies complicated by either or preeclampsia. even though there is some evidence of increased rates associated severe acute respiratory syndrome coronavirus infection we found no increase mrna expression angiotensin-converting enzyme at maternal-fetal interface.&gt;
&lt;/.05&gt;
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32857620" target="_blank">32857620</a>
</td>
<td style="text-align:center;">
This proof of concept demonstrates azithromycin downregulates pathways involving serine proteases TMPRSS2 and TMPRSS11D required for SARS-CoV-2 activation and its cell-to-cell transmission while downregulating pro-inflammatory cytokine IL-1β, NDST-1 and their associated pathways.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32860686" target="_blank">32860686</a>
</td>
<td style="text-align:center;">
We will describe several classes of drugs such as serine protease inhibitors, heparin, heparan sulfate receptor inhibitors, chelating agents, immunomodulators and many others.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32861070" target="_blank">32861070</a>
</td>
<td style="text-align:center;">
And transmembrane protease serine 2 (TMPRSS2) could cleave the spike (S) protein of SARS-CoV-2, which facilitates the fusion of SARS-CoV-2 and cellular membranes.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32861340" target="_blank">32861340</a>
</td>
<td style="text-align:center;">
Transmembrane protease serine 2 (TMPRSS2), which interacts with ACE2, may be a better candidate for targeted therapies.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32861744" target="_blank">32861744</a>
</td>
<td style="text-align:center;">
The zymogen/proenzyme plasminogen is converted to the serine protease plasmin, a key fibrinolytic factor by plasminogen activators including tissue-type plasminogen activator (tPA).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32862058" target="_blank">32862058</a>
</td>
<td style="text-align:center;">
Using comparative immunofluorescence, we examined the localization and relative tissue abundance of SARS-CoV2 spike glycoprotein (CoV2 SP) along with the co-localization of two SARS-CoV2 viral entry proteins angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32863223" target="_blank">32863223</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 infects human cells by binding to the cellular surface protein angiotensin-converting enzyme 2 (ACE2); in addition, the cellular transmembrane serine protease 2 (TMPRSS2) is needed for priming of the spike (S) protein of the virus.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32863636" target="_blank">32863636</a>
</td>
<td style="text-align:center;">
The use of serine protease inhibitors such as ulinastatin has been advised by some experts.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32864545" target="_blank">32864545</a>
</td>
<td style="text-align:center;">
Androgens upregulate the protease TMPRSS2 (type II transmembrane serine protease-2), which facilitates efficient virus-host cell fusion with the epithelium of the lungs, thus increasing susceptibility to SARS-CoV-2 infection and development of severe COVID-19.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32866534" target="_blank">32866534</a>
</td>
<td style="text-align:center;">
Angiotensin-converting enzyme 2 (ACE2) receptor serves as an entry point for this deadly virus while the proteases like furin, transmembrane protease serine 2 (TMPRSS2) and 3 chymotrypsin-like protease (3CLpro) are involved in the further processing and replication of SARS-CoV-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32867666" target="_blank">32867666</a>
</td>
<td style="text-align:center;">
RNA-dependent RNA polymerase (b.) serine protease and (c.) proteolytic activation pathways or the cell membrane receptor called the angiotensin converting enzyme-2 (ACE2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32869854" target="_blank">32869854</a>
</td>
<td style="text-align:center;">
Human serine protease inhibitors (serpins) are the main inhibitors of serine proteases, but some of them also have the capability to effectively inhibit cysteine proteases. […] Mpro target sites with its active site serine and other flanking residues can possibly interact with serpins.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32870433" target="_blank">32870433</a>
</td>
<td style="text-align:center;">
Thrombin is a trypsin-like serine protease with multiple physiological functions.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32873700" target="_blank">32873700</a>
</td>
<td style="text-align:center;">
Transmembrane serine protease 2 is encoded by the TMPRSS2 gene.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32878480" target="_blank">32878480</a>
</td>
<td style="text-align:center;">
To date, no study has examined whether an increased fraction of inspired oxygen (FiO2) may affect the expression of SARS-CoV-2 entry receptors and co-receptors, including ACE2 and the transmembrane serine proteases TMPRSS1, TMPRSS2, and TMPRSS11D.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32883010" target="_blank">32883010</a>
</td>
<td style="text-align:center;">
The ocular surface and retina have the necessary proteins, Transmembrane Serine Protease 2 (TMPRSS2), CD147, Angiotensin-Converting Enzyme 2 (ACE2) and Cathepsin L (CTSL) necessary to be infected with SARS-CoV-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32887532" target="_blank">32887532</a>
</td>
<td style="text-align:center;">
Type II transmembrane serine proteases (TTSPs) of the human respiratory tract generate high interest owing to their ability, among other roles, to cleave surface proteins of respiratory viruses. […] Areas covered: This review includes WIPO-listed patents reporting small molecules and peptide-based inhibitors of type II transmembrane serine proteases of the respiratory tract.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32887634" target="_blank">32887634</a>
</td>
<td style="text-align:center;">
Platelets expressed ACE2, a host cell receptor for SARS-CoV-2, and TMPRSS2, a serine protease for Spike protein priming.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32890967" target="_blank">32890967</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 entry into host cells is characterized by viral spike protein interaction with cellular angiotensin-converting enzyme 2 (ACE2) and serine protease TMPRSS2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32901936" target="_blank">32901936</a>
</td>
<td style="text-align:center;">
The cleavage of the S1-S2 protein, which is required for the conformational changes of the S2 subunit and processing of viral fusion, is regulated by the host proteases, including cathepsin L (during endocytosis) and type II membrane serine protease (independently).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32903321" target="_blank">32903321</a>
</td>
<td style="text-align:center;">
The new coronavirus (SARS-CoV-2), which has been responsible for the recent coronavirus disease 2019 (COVID-19) pandemic, uses the cell receptor angiotensin converting enzyme-2 (ACE2) for entry and the serine protease TMPRSS2 for spike (S) protein priming.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32918208" target="_blank">32918208</a>
</td>
<td style="text-align:center;">
Human factor Xa (FXa) is a serine protease of the common coagulation pathway.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32918944" target="_blank">32918944</a>
</td>
<td style="text-align:center;">
Transmembrane protease serine 2 (TMPRSS2) has been shown to prime the viral spike for its interaction with its receptor.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32926098" target="_blank">32926098</a>
</td>
<td style="text-align:center;">
Mechanistically, NETs triggered by SARS-CoV-2 depend on angiotensin-converting enzyme 2, serine protease, virus replication, and PAD-4.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32936429" target="_blank">32936429</a>
</td>
<td style="text-align:center;">
A tentative hypothesis to explain these findings is the role of angiotensin-converting enzyme 2 (ACE2) and serine protease TMPRSS2 involved in viral infection.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32940922" target="_blank">32940922</a>
</td>
<td style="text-align:center;">
Cellular entry of SARS-CoV-2 depends on the binding of its spike protein to a cellular receptor named angiotensin-converting enzyme 2 (ACE2), and the subsequent spike protein-priming by host cell proteases, including transmembrane protease serine 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32943233" target="_blank">32943233</a>
</td>
<td style="text-align:center;">
Mannan-binding lectin-associated serine protease-2 (MASP-2), the lectin pathway’s effector enzyme, binds the nucleocapsid protein of severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2), resulting in complement activation and lung injury.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32944935" target="_blank">32944935</a>
</td>
<td style="text-align:center;">
Reports denote SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2) as its primary entry point into the host cell.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32947136" target="_blank">32947136</a>
</td>
<td style="text-align:center;">
Furthermore, studies have indicated that the spike proteins of SARS-CoV-2 use the Angiotensin Converting Enzyme-2 (ACE-2) receptor for its attachment similar to SARS-CoV-1, which is followed by priming of spike protein by Transmembrane protease serine 2 (TMPRSS2) which can be targeted by a proven inhibitor of TMPRSS2, camostat.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32948440" target="_blank">32948440</a>
</td>
<td style="text-align:center;">
Glycogen synthase kinase-3 (Gsk-3) is a conserved serine/threonine kinase that mainly participates in cell proliferation, development, stress, and inflammation in humans.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32950067" target="_blank">32950067</a>
</td>
<td style="text-align:center;">
We found that MSCs from bone marrow, amniotic fluid, and adipose tissue carry angiotensin-converting enzyme 2 and transmembrane protease serine subtype 2 at low levels on the cell surface under steady-state and inflammatory conditions.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32954047" target="_blank">32954047</a>
</td>
<td style="text-align:center;">
Interestingly, in ORF8 substitution of Leucine, a nonpolar to Serine a polar amino acid at same position (aa84 L to S) in 23 isolates of five countries i.e.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32955126" target="_blank">32955126</a>
</td>
<td style="text-align:center;">
The receptor for spike protein of SARS-CoV-2, angiotensin 2 converting enzyme (ACE2), and transmembrane protease serine (for viral entry) is expressed in upper gastrointestinal (GI) enterocytes, ACE2 is expressed on enteroendocrine cells (EECs), and SARS-CoV-2 infects enterocytes but not EECs (studies needed with native EECs).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32960480" target="_blank">32960480</a>
</td>
<td style="text-align:center;">
The plasma serine protease inhibitor alpha-1 antitrypsin was suggested to protect from COVID-19 by inhibiting TMPRSS2, a cell surface serine protease essential for the SARS-CoV-2 cell entry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32964796" target="_blank">32964796</a>
</td>
<td style="text-align:center;">
Abbreviations: 3-MA: 3-methyladenine (autophagy inhibitor); AKT/protein kinase B: AKT serine/threonine kinase; ATG: autophagy related; ATPase: adenosine triphosphatase; BMM: bone marrow macrophage; CGAS: cyclic GMP-AMP synthase; CHO: Chinese hamster ovary/cell line; CoV: coronaviruses; COVID-19: Coronavirus disease 2019; DMV: double-membrane vesicle; EAV: equine arteritis virus; EDEM1: ER degradation enhancing alpha-mannosidase like protein 1; ER: endoplasmic reticulum; ERAD: ER-associated degradation; GFP: green fluorescent protein; HCoV: human coronavirus; HIV: human immunodeficiency virus; HSV: herpes simplex virus; IBV: infectious bronchitis virus; IFN: interferon; LAMP1: lysosomal associated membrane protein 1; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MCoV: mouse coronavirus; MERS-CoV: Middle East respiratory syndrome coronavirus; MHV: mouse hepatitis virus; NBR1: NBR1 autophagy cargo receptor; CALCOCO2/NDP52: calcium binding and coiled-coil domain 2 (autophagy receptor that directs cargo to phagophores); nsp: non-structural protein; OS9: OS9 endoplasmic reticulum lectin; PEDV: porcine epidemic diarrhea virus; PtdIns3K: class III phosphatidylinositol 3-kinase; PLP: papain-like protease; pMEF: primary mouse embryonic fibroblasts; SARS-CoV: severe acute respiratory syndrome coronavirus; SKP2: S-phase kinase associated protein 2; SQSTM1: sequestosome 1; STING1: stimulator of interferon response cGAMP interactor 1; ULK1: unc-51 like autophagy activating kinase 1; Vps: vacuolar protein sorting.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32969768" target="_blank">32969768</a>
</td>
<td style="text-align:center;">
These cells, C2BBe1 intestinal cells with a brush border having high levels of transmembrane serine protease 2 (TMPRSS2), showed robust viral propagation, and could be persistently infected with SARS-CoV-2, supporting the clinical observations of persistent GI infection in COVID-19 patients.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32972339" target="_blank">32972339</a>
</td>
<td style="text-align:center;">
The priming of the spike (S) protein of the virus by proteolytic cleavage by the trans-membrane serine protease-2 (TMPRSS2) is necessary for fusion of the virus to the host cell after it binds to its receptor angiotensin converting enzyme-2 (ACE2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32985199" target="_blank">32985199</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 has been shown to use the SARS-CoV receptor ACE2 for entry and serine protease TMPRSS2 for S protein.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32987757" target="_blank">32987757</a>
</td>
<td style="text-align:center;">
There is a vast practice of using antimalarial drugs, RAS inhibitors, serine protease inhibitors, inhibitors of the RNA-dependent RNA polymerase of the virus and immunosuppressants for the treatment of the severe form of COVID-19, which often occurs in patients with chronic diseases and older persons.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32992681" target="_blank">32992681</a>
</td>
<td style="text-align:center;">
The present study aims to investigate the microRNAs that regulate the expression of hypothalamic angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2), essential elements for SARS-CoV-2 cell entry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/32992731" target="_blank">32992731</a>
</td>
<td style="text-align:center;">
Proposed mechanisms involve host cell membrane-bound angiotensin-converting enzyme 2 (ACE2), type II transmembrane serine proteases (TTSPs), such as transmembrane serine protease isoform 2 (TMPRSS2), lysosomal endopeptidase Cathepsin L (CTSL), subtilisin-like proprotein peptidase furin (FURIN), and even potentially membrane bound heparan sulfate proteoglycans.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32993622" target="_blank">32993622</a>
</td>
<td style="text-align:center;">
Abnormalities in the renin-angiotensin-aldosterone system (RAAS), angiotensin-converting enzyme-2 (ACE2) and the androgen-driven transmembrane serine protease 2 (TMPRSS2) have been elicited as key modulators of SARS-CoV-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32994064" target="_blank">32994064</a>
</td>
<td style="text-align:center;">
Artificial intelligence can have an important role in analysing such data to identify populations at higher risk of COVID-19-related urological pathologies and to suggest treatments that block viral entry into cells by interrupting the angiotensin-converting enzyme 2-transmembrane serine protease 2 (ACE2-TMPRSS2) pathway.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32994673" target="_blank">32994673</a>
</td>
<td style="text-align:center;">
S consists of two subunits, S1 and S2, which are cleaved by the widely expressed transmembrane protease serine 2 (TMPRSS2) before the virus fuses to the plasma membrane and infects the cell.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33007239" target="_blank">33007239</a>
</td>
<td style="text-align:center;">
Cleavage and the syncytium are abolished by treatment with the furin inhibitors decanoyl-RVKR-chloromethylketone (CMK) and naphthofluorescein, but not by the transmembrane protease serine 2 (TMPRSS2) inhibitor camostat.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33008593" target="_blank">33008593</a>
</td>
<td style="text-align:center;">
We determined the expression levels of receptor ACE2 and CD147, and serine protease TMPRSS2 in human and mouse brain cell lines and mouse different region of brain tissues with qRT-PCR and Western blot.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33011745" target="_blank">33011745</a>
</td>
<td style="text-align:center;">
Here, we determined the expression of the SARS-CoV2 receptor, angiotensin converting enzyme 2 (ACE2) and its associated cellular serine protease TPMRSS2 in the dental pulp under normal and inflamed conditions.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33015550" target="_blank">33015550</a>
</td>
<td style="text-align:center;">
Additionally, transmembrane serine protease 2 (TMPRSS2) and furin facilitate virus entry into the host.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33029419" target="_blank">33029419</a>
</td>
<td style="text-align:center;">
ACE2: Angiotensin-converting enzyme 2; COVID-19: coronavirus disease 2019; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; HIV: human immunodeficiency virus; IRB, Institutional Review Board; ISH, in situ hybridisation; RT-PCR: reverse transcriptase-PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus-2; TMPRSS2: transmembrane protease, serine 2; WBC: white blood cell.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33029570" target="_blank">33029570</a>
</td>
<td style="text-align:center;">
Entry of SARS-CoV-2, etiological agent of COVID-19, in the host cell is driven by the interaction of its spike protein with human ACE2 receptor and a serine protease, TMPRSS2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33031797" target="_blank">33031797</a>
</td>
<td style="text-align:center;">
According to bulk RNA and single cell RNA sequencing analysis, we found that high expression of both angiotensin converting enzyme 2 (ACE2) and transmembrane Serine Protease 2 (TMPRSS2) makes the lung and intestine vulnerable to SARS-CoV-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33032170" target="_blank">33032170</a>
</td>
<td style="text-align:center;">
For ACE2 mediated cell entry of the SARS-CoV-2, co-expression of one more protein-Transmembrane protease serine 2 (TMPRSS2) is essential.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33035337" target="_blank">33035337</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 uses human angiotensin-converting enzyme 2 (ACE2) for viral entry and transmembrane serine protease family member II (TMPRSS2) for spike protein priming.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33042335" target="_blank">33042335</a>
</td>
<td style="text-align:center;">
One of the known regulators of endocytosis is the serine protease (TMPRSS2) and AP2-associated protein kinase 1 (AAK1), which also facilitates the passage of viruses into cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33042994" target="_blank">33042994</a>
</td>
<td style="text-align:center;">
Following the binding of the S1 receptor-binding domain (RBD) to ACE2, transmembrane protease/serine subfamily 2 (TMPRSS2) cleaves the S2 domain to facilitate membrane fusion.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33043235" target="_blank">33043235</a>
</td>
<td style="text-align:center;">
FXa, a serine protease, has been shown to play a role in the cleavage of SARS-CoV-1 spike protein (SP), with the inhibition of FXa resulting in the inhibition of viral infectivity.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33043253" target="_blank">33043253</a>
</td>
<td style="text-align:center;">
This work makes an assessment of wildlife susceptibility to SARS-CoV-2 by analyzing the similarities of Angiotensin Converting Enzyme 2 (ACE2) and Transmembrane Protease, Serine 2 (TMPRSS2) -both recognized as receptors and protease for coronavirus spike protein- and the genetic variation of the viral protein spike in the recognition sites.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33049583" target="_blank">33049583</a>
</td>
<td style="text-align:center;">
Then, the spike protein of SARS-CoV-2 can be cleaved and activated by transmembrane protease, serine 2 (TMPRSS2) of the host cells for SARS-CoV-2 infection.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33051876" target="_blank">33051876</a>
</td>
<td style="text-align:center;">
On the contrary, the TMPRSS2 serine protease, which is known to enhance infectivity of cell-free virions, processes both S and ACE2 and increases syncytia formation by accelerating the fusion process.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33061814" target="_blank">33061814</a>
</td>
<td style="text-align:center;">
Here we profiled two SARS-CoV-2 infection related genes, the transmembrane serine protease 2 (TMPRSS2) and the interferon-inducible transmembrane protein 3 (IFITM3), in human tissues and organs.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33062480" target="_blank">33062480</a>
</td>
<td style="text-align:center;">
This review includes data on the roles of the S protein, ACE2 (angiotensin-converting enzyme 2) receptor, and various human secretory proteases, such as transmembrane protease/serine subfamily member 2 and furin, in the pathogenesis of SARS-CoV-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33066495" target="_blank">33066495</a>
</td>
<td style="text-align:center;">
As such, this paper focuses on the potential role of BPA in promoting comorbidities associated with severe COVID-19, as well as on potential BPA-induced effects on key SARS-CoV-2 infection mediators, such as angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33072093" target="_blank">33072093</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 infection is mediated by the binding of viral Spike proteins (S-protein) to human cells through a 2-step process, which involves Angiotensin Converting Enzyme-2 (ACE2) and Transmembrane Serine Protease (TMPRSS)-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33073699" target="_blank">33073699</a>
</td>
<td style="text-align:center;">
Gene network analysis confirmed that G-protein coupled receptor, protein kinase B signaling, protein secretion, peptidyl-serine phosphorylation, nuclear transport, apoptotic pathway, tumor necrosis factor, regulation of angiotensin level, positive regulation of ion transport, and membrane protein proteolysis were altered during COVID-19.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33088671" target="_blank">33088671</a>
</td>
<td style="text-align:center;">
Activation of the lectin pathway via mannose-binding lectin associated serine protease 2 (MASP2) is witnessed under discrete viral infections including COVID-19.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33091758" target="_blank">33091758</a>
</td>
<td style="text-align:center;">
The evidence of transmembrane protease, serine 2 (TMPRSS2) expression in lung tissue, which is an androgen-regulated gene and expressed mainly in the adult prostate may interpret the increased susceptibility of the male gender to severe COVID-19 complications.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33098835" target="_blank">33098835</a>
</td>
<td style="text-align:center;">
Bioactive peptides with unique amino acid sequences can mitigate such targets including, type II transmembrane serine proteases (TMPRSS2) inhibition, furin cleavage, and renin-angiotensin-aldosterone system (RAAS) members.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33108902" target="_blank">33108902</a>
</td>
<td style="text-align:center;">
Considering the limited data on cancer patients, we analyzed public data repositories limited to investigate angiotensin-converting enzyme 2 (ACE2) and the transmembrane serine protease 2 (TMPRSS2) expressions and genetic variants to identify the basis of individual susceptibility to SARS-CoV-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33109028" target="_blank">33109028</a>
</td>
<td style="text-align:center;">
Natural products intervene at various stages of the virus replication cycle, including inhibition of virus entry into the host cells, inhibition of serine/ cysteine proteases, RNA-dependent RNA polymerase (RdRp) or helicase.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33110240" target="_blank">33110240</a>
</td>
<td style="text-align:center;">
We discussed a possible link between the activation of hypoxia inducible factor 1α (HIF-1α) and cell entry of SARS-CoV-2, since HIF-1α is shown to suppress the angiotensin-converting enzyme 2 (ACE2) receptor and transmembrane protease serine 2 (TMPRSS2) and upregulate disintegrin and metalloproteinase domain-containing protein 17 (ADAM17).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33117379" target="_blank">33117379</a>
</td>
<td style="text-align:center;">
Therefore, the occurrence of specific comorbidities associated with renin-angiotensin system (RAS) imbalance mediated by the interaction between angiotensin-converting enzyme 2 (ACE2) and desintegrin and metalloproteinase domain 17 (ADAM17), along with specific genetic factors mainly associated with type II transmembrane serine protease (TMPRSS2) expression, could be decisive for the clinical outcome of COVID-19.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33117437" target="_blank">33117437</a>
</td>
<td style="text-align:center;">
The observed role of androgens in transcription of transmembrane protease serine-2, which facilitates COVID-19 anchoring to angiotensin-converting enzyme 2 cell surface receptors, seems to suggest that higher testosterone levels might be detrimental for outcomes.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33119197" target="_blank">33119197</a>
</td>
<td style="text-align:center;">
Most, but not all, transcriptomic and proteomic analyses fail to observe the putative SARS-CoV-2 receptor, angiotensin converting enzyme-2, or the cellular serine protease necessary for viral entry, TMPRSS2, on platelets and megakaryocytes.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33125431" target="_blank">33125431</a>
</td>
<td style="text-align:center;">
Angiotensin-converting enzyme 2 (ACE2) has been implicated in the pathogenesis of chronic kidney disease (CKD) and is a membrane receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease (COVID-19), whereas transmembrane protease, serine 2 (TMPRSS2) is involved in viral attachment.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33130280" target="_blank">33130280</a>
</td>
<td style="text-align:center;">
Herein, we selected transmembrane protease serine 2 (TMPRSS2) enzyme, a potential pharmacological target against SARS-CoV-2, involved in the spread and pathogenesis of the virus. […] The catalytic triad consisting of Serine-441, Histidine-296 and Aspartic acid-345 was identified as active binding site of TMPRSS2 using existing ligands.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33137894" target="_blank">33137894</a>
</td>
<td style="text-align:center;">
SARS-CoV2 infection depends on the host cell Angiotensin-Converting Enzyme-2 (ACE2) and Transmembrane Serine Protease-2 (TMPRSS2), where the virus uses ACE2 for entry and TMPRSS2 for S protein priming. […] The TMPRSS2 gene encodes a Transmembrane Protease Serine-2 protein (TMPS2) that belongs to the serine protease family.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33141332" target="_blank">33141332</a>
</td>
<td style="text-align:center;">
The current body of evidence indicates that SARS-CoV‑2 requires the membrane-bound angiotensin-converting enzyme 2 (ACE2) and the membrane-bound serine protease TMPRSS2 to enter cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33143053" target="_blank">33143053</a>
</td>
<td style="text-align:center;">
The two main co-factors needed by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter human cells are angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33148439" target="_blank">33148439</a>
</td>
<td style="text-align:center;">
Additionally, we tested the association of genetic variants in two key genes related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2), with COVID-19 or any other phenotypes. ), was obtained.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33150674" target="_blank">33150674</a>
</td>
<td style="text-align:center;">
For a virus to be pathogenic, in addition to its affinity (tropism) for specific tissue(s), host cells must allow viral entry, and discuss the important role played by transmembrane protease, serine 2 (TMPRSS2) and coexpression of both ACE2 and TMPRSS2 in the same cells is important to cause damage.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33153216" target="_blank">33153216</a>
</td>
<td style="text-align:center;">
The expression of apparatus mediating SARS-CoV-2 entry, including angiotensin-converting enzyme 2, transmembrane protease serine 2 (TMPRSS2) and a disintegrin and metalloprotease 17 (ADAM17), within the renal tubular cells is highly associated with acute kidney injury mediated by SARS-CoV-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33153403" target="_blank">33153403</a>
</td>
<td style="text-align:center;">
: ACE2, angiotensin converting enzyme II; βCoV, betacoronavirus; COVID-19, Coronavirus Disease 2019; CQ, chloroquine; DMV, double-membrane vesicle; GI, gastrointestinal; HCQ, hydroxychloroquine; IL, interleukin; MAP1LC3/LC3, microtubule associated protein 1 light chain 3; MEFs, mouse embryonic fibroblasts; MERS-CoV, Middle East respiratory syndrome coronavirus; MHV, murine hepatitis virus; PE, phosphatidylethanolamine; SARS-CoV, severe acute respiratory syndrome coronavirus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TMPRSS2, transmembrane serine protease 2; TNF, tumor necrosis factor; WHO, World Health Organization.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33154233" target="_blank">33154233</a>
</td>
<td style="text-align:center;">
The presence of angiotensin-converting enzyme 2 receptor and transmembrane serine protease 2, which are the key proteins of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry process, in the GI tract can explain the digestive symptoms in COVID-19.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33157292" target="_blank">33157292</a>
</td>
<td style="text-align:center;">
Nafamostat, a serine proteinase inhibitor with various actions including antithrombin, antiplasmin, and antitrypsin effects, has been used in clinical practice to treat disseminated intravascular coagulation (DIC) and pancreatitis.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33164230" target="_blank">33164230</a>
</td>
<td style="text-align:center;">
There is growing evidence that androgen-enabled expression of ACE2 receptors and the serine protease TMPRSS2, two permissive elements engaging the SARS-CoV-2 spike protein for infection, may contribute to severe COVID-19 in men.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33168188" target="_blank">33168188</a>
</td>
<td style="text-align:center;">
The host-cell receptor angiotensin converting enzyme 2 (ACE2) and the type II transmembrane serine protease (TMPRSS2) are important for viral cell entry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33174447" target="_blank">33174447</a>
</td>
<td style="text-align:center;">
These proteins include the viral receptor, angiotensin-converting enzyme 2 (ACE2), and the proteases, transmembrane serine protease 2 (TMPRSS2) and furin.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33176395" target="_blank">33176395</a>
</td>
<td style="text-align:center;">
Camostat mesylate, an orally available well-known serine protease inhibitor, is a potent inhibitor of TMPRSS2 and has been hypothesized as a potential antiviral drug against COVID-19.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33179220" target="_blank">33179220</a>
</td>
<td style="text-align:center;">
SARS-COV2 virus spike proteins utilize Transmembrane protease serine 2 (TMPRSS2) for host entry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33182653" target="_blank">33182653</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 interacts with angiotensin-converting enzyme 2 and TMPRSS2, which is a serine protease both expressed in lungs, the gastro-intestinal tract, and cardiac myocytes.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33186231" target="_blank">33186231</a>
</td>
<td style="text-align:center;">
Receptor binding and spike glycoprotein priming by host proteases such as furin and transmembrane protease serine 2 induce pre to postfusion conformational changes of the spike trimer that enable membrane fusion.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33188579" target="_blank">33188579</a>
</td>
<td style="text-align:center;">
Angiotensin-converting enzyme 2 (ACE2) and type II transmembrane serine protease (TMPRSS2) are the main host cell factors for the Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) entry but so far it is unclear if human MSCs express or do not these two proteins.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33189768" target="_blank">33189768</a>
</td>
<td style="text-align:center;">
Here, we summarize the current status of peptides inhibiting SARS-CoV-2 entry and outline the strategies used to design peptides targeting the ACE2 receptor or the viral spike protein and its activating proteases furin, transmembrane serine protease 2 (TMPRSS2), or cathepsin L.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33193407" target="_blank">33193407</a>
</td>
<td style="text-align:center;">
Those PRM form complexes with MBL-associated serine proteases (MASP-1, MASP-2, MASP-3) and related non-enzymatic factors (MAp19, MAp44).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33196058" target="_blank">33196058</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 appears to infect cells by first binding and priming its viral-spike proteins with membrane-associated angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33200379" target="_blank">33200379</a>
</td>
<td style="text-align:center;">
The protein targets used in this study were: SARS-CoV-2 spike glycoprotein, angiotensin-converting enzyme 2, furin and transmembrane serine protease 2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33202948" target="_blank">33202948</a>
</td>
<td style="text-align:center;">
Notably, we provided evidence, for the first time, that angiotensin-converting enzyme 2, a receptor to mediate the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2) entry into target cells, and the cofactor transmembrane protease serine 2 were significantly upregulated in both hPSC-AECs and AOs treated with dPM2.5.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33207245" target="_blank">33207245</a>
</td>
<td style="text-align:center;">
This would require binding and entry of SARS-CoV-2 into β cells via co-expression of its canonical cell entry factors, angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2); however, their expression in human pancreas has not been clearly defined.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33208167" target="_blank">33208167</a>
</td>
<td style="text-align:center;">
The formation of hydrogen bonds between this serine-type protease and garlic bioactives in the active site regions inhibits the COVID-19 outbreak.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33210953" target="_blank">33210953</a>
</td>
<td style="text-align:center;">
(papain-like protease), RdRp (RNA-dependent RNA polymerase), S protein (viral spike glycoprotein), TMPRSS2 (transmembrane protease serine 2), ACE2 (angiotensin-converting enzyme 2), and AT2 (angiotensin AT2 receptor) are important targets.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33225308" target="_blank">33225308</a>
</td>
<td style="text-align:center;">
Severe acute respiratory syndrome coronavirus 2 cell entry depends on angiotensin-converting enzyme 2 and transmembrane serine protease 2 and is blocked in cell culture by camostat mesylate, a clinically proven protease inhibitor.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33239231" target="_blank">33239231</a>
</td>
<td style="text-align:center;">
First, AAT is a serine protease inhibitor (SERPIN) shown to inhibit TMPRSS-2, the host serine protease that cleaves the spike protein of SARS-CoV-2, a necessary preparatory step for the virus to bind its cell surface receptor ACE2 to gain intracellular entry. […] Fourth, AAT inhibits neutrophil elastase, a serine protease that helps recruit potentially injurious neutrophils and implicated in acute lung injury.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33239694" target="_blank">33239694</a>
</td>
<td style="text-align:center;">
Among the top-ranked PSM which recorded lower binding energy (BE), &gt; 50% were triterpenoids which interacted strongly with viral spike protein-receptor binding domain, &gt; 32% molecules which showed better interaction with the active site of human transmembrane serine protease were belongs to flavonoids and their glycosides, &gt; 16% of flavonol glycosides and &gt; 16% anthocyanidins recorded lower BE against active site of viral main protease and &gt; 13% flavonol glycoside strongly interacted with active site of viral RNA-dependent RNA polymerase.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33241508" target="_blank">33241508</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 uses ACE2 combined with the transmembrane protease serine 2 (TMPRSS2) as the key molecular complex to infect the host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33252294" target="_blank">33252294</a>
</td>
<td style="text-align:center;">
Estradiol protects the vascular system, mediating with the renin-angiotensin-aldosterone system, whereas testosterone enhances the levels of angiotensin-converting enzyme and the transmembrane protease serine-type 2, thus delaying viral clearance in men as compared to women.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33254575" target="_blank">33254575</a>
</td>
<td style="text-align:center;">
Further, cleavage of the viral spike protein (S) by the proteases like transmembrane serine protease 2 (TMPRSS2) or Cathepsin L (CTSL) is essential to effectuate host cell membrane fusion and virus infectivity.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33254589" target="_blank">33254589</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 utilizes Angiotensin-Converting Enzyme II (ACE2) for entry in the host cell, and Transmembrane Protease, Serine 2 (TMPRSS2) to prime spike protein of SARS-CoV-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33262177" target="_blank">33262177</a>
</td>
<td style="text-align:center;">
The former include: (1) age-related increase in endothelial damage and changes in clotting function; (2) higher density, increased affinity and different distribution of angiotensin converting enzyme 2 receptors and transmembrane serine protease 2; (3) pre-existing coronavirus antibodies (including antibody-dependent enhancement) and T cells; (4) immunosenescence and inflammaging, including the effects of chronic cytomegalovirus infection; (5) a higher prevalence of comorbidities associated with severe COVID-19 and (6) lower levels of vitamin D.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33268377" target="_blank">33268377</a>
</td>
<td style="text-align:center;">
I hypothesize that several membrane-associated serine proteinases (MASPs), in synergy with or in place of TMPRSS2, contribute to activate the SARS-CoV-2 spike protein.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33270159" target="_blank">33270159</a>
</td>
<td style="text-align:center;">
The highly conserved architecture of the coronavirus N protein consists of an N-terminal RNA-binding domain (NTD), followed by an intrinsically disordered Serine/Arginine (SR)-rich linker and a C-terminal dimerization domain (CTD).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33273695" target="_blank">33273695</a>
</td>
<td style="text-align:center;">
The receptor-interacting serine/threonine protein kinase 1 (RIPK1) is a key mediator of regulated cell death and inflammation.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33278189" target="_blank">33278189</a>
</td>
<td style="text-align:center;">
The virus requires proteolytic processing of its spike protein by transmembrane protease receptor serine type 2 (TMPRSS2) to enable binding to cellular ACE2. […] They are inhibited by protease nexin 1 or serine E2 (PN1) that is upregulated by angiotensin II but downregulated by aldosterone.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33289868" target="_blank">33289868</a>
</td>
<td style="text-align:center;">
At the time of the research, angiotensin-converting enzyme 2 (ACE2) was clearly identified as the receptor and transmembrane serine protease 2 (TMPRSS2) as the necessary protease to enable the infection of human cells with SARS-CoV‑2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33290397" target="_blank">33290397</a>
</td>
<td style="text-align:center;">
The host serine protease TMPRSS2 and cysteine proteases Cathepsin B/L can activate S, making two independent entry pathways accessible to SARS-CoV-2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33292872" target="_blank">33292872</a>
</td>
<td style="text-align:center;">
By using publicly available datasets we qualified epithelial ACE2 expression in human intestine, and assessed gene co-expression of ACE2 and SARS-CoV-2 priming Transmembrane Serine Protease 2 (TMPRSS2) with nAChRs in intestinal epithelial cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33293627" target="_blank">33293627</a>
</td>
<td style="text-align:center;">
We aimed at identifying genes co-expressed with angiotensin I converting enzyme 2 (ACE2) the human cell entry receptor of SARS-CoV-2, and unveiled several genes correlated or inversely correlated with high significance, among the most significant of these was the transmembrane serine protease 4 (TMPRSS4). […] Serine proteases are known to be involved in the infection process by priming the virus spike protein.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33296096" target="_blank">33296096</a>
</td>
<td style="text-align:center;">
Intracellular entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) depends on the interaction between its spike protein with the cellular receptor angiotensin-converting enzyme 2 (ACE2) and depends on Furin-mediated spike protein cleavage and spike protein priming by host cell proteases, including transmembrane protease serine 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33297431" target="_blank">33297431</a>
</td>
<td style="text-align:center;">
Sequential cleavage of viral S protein by furin and transmembrane serine protease 2 (TMPRSS2) triggers viral entry to release the viral genome into the target cell.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33299610" target="_blank">33299610</a>
</td>
<td style="text-align:center;">
However, it appears that S protein proteolytic cleavage is dependent on (1) furin and (2) serine protease transmembrane protease serine 2 proteases acting in tandem.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33301987" target="_blank">33301987</a>
</td>
<td style="text-align:center;">
Here, we used diversity analysis of the angiotensin I converting enzyme 2 (ACE2) that serves as cellular receptor for SARS-CoV-2 and transmembrane protease serine 2 (TMPRSS2), which has been proved to be utilized by SARS-CoV-2 for spike protein priming.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33312128" target="_blank">33312128</a>
</td>
<td style="text-align:center;">
Several studies have been carried out to ascertain the presence of SARS-CoV-2 in the seminal fluid, with contrasting results; the expression of angiotensin-converting enzyme-2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in the testes and in the male genital tract led to speculation about the possible presence of the virus in the seminal fluid.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33318519" target="_blank">33318519</a>
</td>
<td style="text-align:center;">
Cell entry of SARS-CoV-2, the novel coronavirus causing COVID-19, is facilitated by host cell angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33324224" target="_blank">33324224</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 appears to infect cells by first binding viral spike proteins with host protein angiotensin-converting enzyme 2 (ACE2) receptors; the virus is endocytosed following priming by transmembrane protease serine 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33328008" target="_blank">33328008</a>
</td>
<td style="text-align:center;">
Angiotensin-converting enzyme 2 (ACE2), one of the binding sites for SARS-CoV-2 infection in humans, can bind to viral spike proteins, allowing transmembrane serine protease (TMPRSS2) to activate S-protein to trigger infection and induce the production of various inflammatory factors such as interleukin-1, interferon-l, and tumor necrosis factor.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33330557" target="_blank">33330557</a>
</td>
<td style="text-align:center;">
In addition, Transmembrane serine protease 2 (TMPRSS2) can enhance ACE2-mediated virus entry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33334457" target="_blank">33334457</a>
</td>
<td style="text-align:center;">
Apart from direct viral attack via angiotensin-converting enzyme 2 and transmembrane serine proteases 2, hypoxia and hypercoagulability also may contribute to the occurrence of renal injury.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33351086" target="_blank">33351086</a>
</td>
<td style="text-align:center;">
Nonoverlapping placental expression of SARS-CoV-2 receptors angiotensin-converting enzyme 2 and transmembrane serine protease 2 was noted. […] Lack of viremia and reduced coexpression and colocalization of placental angiotensin-converting enzyme 2 and transmembrane serine protease 2 may serve as protective mechanisms against vertical transmission.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33362565" target="_blank">33362565</a>
</td>
<td style="text-align:center;">
Recently, A1AT has been found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by inhibiting transmembrane serine protease 2 (TMPRSS2), a protease involved in the entry of SARS-CoV-2 into host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33362695" target="_blank">33362695</a>
</td>
<td style="text-align:center;">
We found that the mRNAs encoding the ACE2 receptor and the TMPRSS2 transmembrane serine protease, both of which are required for viral entry into host cells, are minimally expressed in the major cell types of the brain.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33368788" target="_blank">33368788</a>
</td>
<td style="text-align:center;">
Recently, it has been identified from several studies that angiotensin-converting enzyme 2 receptor and transmembrane serine protease 2 are the main entry molecules for the SARS-CoV-2, which produced the pandemic of Covid-19.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33369281" target="_blank">33369281</a>
</td>
<td style="text-align:center;">
Although pulmonary epithelial cells may rely mainly on plasma membrane serine protease TMPRSS2 for cell entry, PPIs/NHEIs might be efficacious in ACE2-expressing cells where viral endocytosis is the major or a contributing entry pathway.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33372179" target="_blank">33372179</a>
</td>
<td style="text-align:center;">
Since AT2 cells express the SARS-CoV-2 receptors angiotensin converting enzyme (ACE2) and transmembrane protease/serine subfamily member 2 (TMPRSS2), their expression should decline as AT2 cells are depleted by hyperoxia.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33372574" target="_blank">33372574</a>
</td>
<td style="text-align:center;">
), and one human cellular transmembrane serine proteinase (TMPRSS2), was carried out. […] Flabelliferin was found to the best promising inhibitor of human cellular transmembrane serine proteinase, followed by nelfinavir, curcumin, piperine and marmelosin. […] The result on the inhibition of human cellular transmembrane serine proteinase against COVID-19 has a stable therapeutic advantage as mutation may quickly occur on viral drug targets.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33375616" target="_blank">33375616</a>
</td>
<td style="text-align:center;">
The human serine protease serine 2 TMPRSS2 is involved in the priming of proteins of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and represents a possible target for COVID-19 therapy.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33380345" target="_blank">33380345</a>
</td>
<td style="text-align:center;">
There is accumulating evidence that cerebral hypoperfusion accelerates amyloid-β (Aβ) accumulation and is linked to tau and TDP-43 pathology, and by inducing phosphorylation of α-synuclein at serine-129, ischaemia may also increase the risk of development of Lewy body disease.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33383190" target="_blank">33383190</a>
</td>
<td style="text-align:center;">
In this review, we have recapitulated the structural details of four key viral enzymes, RNA-dependent RNA polymerase, 3-chymotrypsin like protease, papain-like protease and helicase, and two host factors including angiotensin-converting enzyme 2 and transmembrane serine protease involved in the SARS-CoV-2 pathogenesis, and described the potential hotspots present on these structures which could be explored for therapeutic intervention.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33388025" target="_blank">33388025</a>
</td>
<td style="text-align:center;">
On one hand, this is attributable to the fact that T may facilitate SARS-CoV-2 entry in human cells by means of an enhanced expression of transmembrane serine-protease 2 (TMPRSS2) and angiotensin-converting enzyme 2 (ACE2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33391755" target="_blank">33391755</a>
</td>
<td style="text-align:center;">
The three patients and patients with other AKI did not differ significantly with regard to angiotensin-converting enzyme 2 and transmembrane protease serine 2 kidney staining.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33391931" target="_blank">33391931</a>
</td>
<td style="text-align:center;">
The receptor for SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2), as well as the necessary protease to facilitate viral entry, transmembrane protease serine-2 (TMPRSS2), and to a lesser extent, cathepsins, have been demonstrated to be present throughout the gastrointestinal tract, thus facilitating viral entry and pathogenesis.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33393462" target="_blank">33393462</a>
</td>
<td style="text-align:center;">
Moreover, the MBCS increased entry speed and plasma membrane serine protease usage relative to cathepsin-mediated endosomal entry. […] Blocking serine proteases, but not cathepsins, effectively inhibited SARS-CoV-2 entry and replication in hAOs. […] Our findings demonstrate that SARS-CoV-2 enters relevant airway cells using serine proteases, and suggest that the MBCS is an adaptation to this viral entry strategy.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33394891" target="_blank">33394891</a>
</td>
<td style="text-align:center;">
SARS-CoV-2 enters host cells via angiotensin converting enzyme-2 (ACE2) and the serine protease TMPRSS2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33397514" target="_blank">33397514</a>
</td>
<td style="text-align:center;">
Interestingly, serine protease transmembrane serine protease 2 (TMPRSS2) had less expression in cardiomyocytes, but CTSB and CTSL, which belonged to cell protease, could be found to be enriched in cardiomyocytes.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33405098" target="_blank">33405098</a>
</td>
<td style="text-align:center;">
Successful entry of SARS-CoV-2 into the body is dependent on the angiotensin-converting enzyme 2 (ACE2) receptor and the transmembrane protease serine 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33408715" target="_blank">33408715</a>
</td>
<td style="text-align:center;">
CD95 (Fas) and serine-threonine kinase (Akt).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33409413" target="_blank">33409413</a>
</td>
<td style="text-align:center;">
) inhibitors of host transmembrane protease serine 2 (TMPRSS2), endosomal trafficking, and pyrimidine synthesis.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33413387" target="_blank">33413387</a>
</td>
<td style="text-align:center;">
Angiotensin converting enzyme-2 (ACE2) and the enzyme proteases, transmembrane protease serine 2 (TMPRSS2) and FURIN, are needed for viral attachment and invasion into host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33414908" target="_blank">33414908</a>
</td>
<td style="text-align:center;">
Genes that have been indicated to mediate viral entry into host cells such as angiotensin-converting enzyme 2 and transmembrane protease serine 2 are expressed in the lung tissue, a fact that could partially explain COVID-19 pathogenesis and lung involvement.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33421967" target="_blank">33421967</a>
</td>
<td style="text-align:center;">
The distribution of cells expressing SARS-CoV-2 entry factor angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in human oral tissues were tested.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33421977" target="_blank">33421977</a>
</td>
<td style="text-align:center;">
This study aimed to examine the expressions of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in tumor tissues of six common cancer types.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33422505" target="_blank">33422505</a>
</td>
<td style="text-align:center;">
In this study, we used a mouse model exposed to crude PM, collected by the cyclone method, to evaluate the pulmonary expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine type 2 (TMPRSS2), the two molecules required for the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into host cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33426683" target="_blank">33426683</a>
</td>
<td style="text-align:center;">
Other important proteins involved in this process include disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) also known as tumour necrosis factor-α-converting enzyme and transmembrane serine protease 2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33439572" target="_blank">33439572</a>
</td>
<td style="text-align:center;">
The coronavirus S protein mediates viral entry into target cells employing the host cellular serine protease TMPRSS2 for S-protein priming.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33450625" target="_blank">33450625</a>
</td>
<td style="text-align:center;">
Transmembrane protease serine 2 (TMPRSS2) has been found to be critical in priming the viral spike protein and the host ACE2 receptor before the virus enters into the host cell.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33450678" target="_blank">33450678</a>
</td>
<td style="text-align:center;">
Vitamins (A, B, C, D, and E), minerals (selenium and zinc), and bioactive substances from curcumin, echinacea, propolis, garlic, soybean, green tea, and other polyphenols were identified as having potential roles in interfering with spike glycoproteins, angiotensin converting enzyme 2, and transmembrane protease serine 2 at the entry site, and inhibiting activities of papain-like protease, 3 chymotrypsin-like protease, and RNA-dependent RNA polymerase in the replication cycle of severe acute respiratory syndrome coronavirus 2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33455043" target="_blank">33455043</a>
</td>
<td style="text-align:center;">
It is caused by SARS-CoV-2 that requires the ACE2 receptor and serine proteases to enter AEC.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33466589" target="_blank">33466589</a>
</td>
<td style="text-align:center;">
Infiltration and spread of SARS-CoV-2 are based on the interaction between the virus’ structural protein S and the cell’s receptor-angiotensin-converting enzyme 2 (ACE2), with the simultaneous involvement of human trans-membrane protease, serine 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33467896" target="_blank">33467896</a>
</td>
<td style="text-align:center;">
It is now known that the structural spike (S) protein of the SARS-CoV-2 undergoes proteolytic priming by the host serine proteases for entry into the host cells, and N- and O-glycosylation by the host cell enzymes during virion packaging, which enable the virus to spread.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33470589" target="_blank">33470589</a>
</td>
<td style="text-align:center;">
Angiotensin converting enzyme 2 (ACE2) is the principal host cell receptor for SARS-CoV-2 entry and Transmembrane Protease Serine 2 (TMRSS2) is the main priming protease.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33476327" target="_blank">33476327</a>
</td>
<td style="text-align:center;">
These alterations were shown to result from their inability to utilize the entry pathway involving direct fusion mediated by the host type II transmembrane serine protease, TMPRSS2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33477294" target="_blank">33477294</a>
</td>
<td style="text-align:center;">
It has been proposed that spironolactone may prevent acute lung injury in COVID-19 infection due to its pleiotropic effects with favorable renin-angiotensin-aldosterone system (RAAS) and ACE2 expression, reduction in transmembrane serine protease 2 (TMPRSS2) activity and antiandrogenic action, and therefore it may prove to act as additional protection for patients at highest risk of severe pneumonia.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33479198" target="_blank">33479198</a>
</td>
<td style="text-align:center;">
Here we demonstrate that the N protein’s central disordered domain drives phase separation with RNA, and that phosphorylation of an adjacent serine/arginine rich region modulates the physical properties of the resulting condensates.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33486202" target="_blank">33486202</a>
</td>
<td style="text-align:center;">
There is also an indirect option to target the host cell recognition systems such as angiotensin-converting enzyme 2 (ACE2), transmembrane protease, serine 2, host cell expressed CD147, and the host furin.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33486479" target="_blank">33486479</a>
</td>
<td style="text-align:center;">
Virus-cell fusion is mediated by angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) with their organ expression pattern determining viral tropism.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33488517" target="_blank">33488517</a>
</td>
<td style="text-align:center;">
ACE2 receptor and TMPRSS2 serine protease were colocalized in adrenocortical cells in zona fasciculata and zona reticularis.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33506114" target="_blank">33506114</a>
</td>
<td style="text-align:center;">
The third variant, represented by 5%, showed aspartate substitution to tyrosine at D1139Y, and the fourth variant, represented by 5% glycine substitution to serine at G1167S.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33512650" target="_blank">33512650</a>
</td>
<td style="text-align:center;">
Several drug targets have been reported to inhibit the SARS-CoV-2 virus infection, in that TMPRSS2 (transmembrane protease serine 2) is one of the potential targets; inhibiting this protease stops the virus entry into the host human cell.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33513400" target="_blank">33513400</a>
</td>
<td style="text-align:center;">
CHEMICAL COMPOUNDS: Angiotensin-converting enzyme 2 (ACE2); atrial natriuretic peptide (ANP); cathepsin L; heparan sulphate proteoglycans (HSPGs); interferon; interleukin; oxytocin; superoxide dismutase; transmembrane serine protease isoform 2 (TMPRSS2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33522308" target="_blank">33522308</a>
</td>
<td style="text-align:center;">
Androgen receptor (AR) signaling in the transmembrane protease serine 2 (TMPRSS2) regulation is emerging as an important determinant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) susceptibility.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33524188" target="_blank">33524188</a>
</td>
<td style="text-align:center;">
Moreover, SF2809E, an inhibitor of serine protease chymase (an enzyme generating most tissue angiotensin II) may also block TMPRRS2, a host serine protease that primes SARS-CoV-2 spike glycoprotein before adhesion to ACE2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33525682" target="_blank">33525682</a>
</td>
<td style="text-align:center;">
To validate the potential entry of SARS-CoV-2 infection in the retina, we showed that hiPSC-derived retinal organoids and monolayer cultures endogenously express ACE2 and transmembrane serine protease 2 (TMPRSS2) on the mRNA level.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33532640" target="_blank">33532640</a>
</td>
<td style="text-align:center;">
), RNA-dependent RNA polymerase (RdRp), helicase, and serine protease.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33539819" target="_blank">33539819</a>
</td>
<td style="text-align:center;">
As there is no specific drug treatment available for COVID-19 pandemic, we explored in silico repurposing of drugs with dual inhibition properties by targeting transmembrane serine protease 2 (TMPRSS2) and human angiotensin-converting enzyme 2 (ACE2) from FDA-approved drugs.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33541739" target="_blank">33541739</a>
</td>
<td style="text-align:center;">
Although many COVID-19 placental studies have focused on the expression of the canonical SARS-CoV-2 entry proteins angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2, further characterization of subcellular molecules involved in viral trafficking have not yet been investigated in these tissues.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33543899" target="_blank">33543899</a>
</td>
<td style="text-align:center;">
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), uses two primary receptors, type II transmembrane serine protease and angiotensin-converting enzyme-2, for priming and cellular invasion, respectively.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33549263" target="_blank">33549263</a>
</td>
<td style="text-align:center;">
Specific examples include the observation that androgens regulate the expression of the enzyme transmembrane protease, serine 2 which facilitates severe acute respiratory syndrome coronavirus 2 viral entry into the cell; therefore, androgen deprivation therapy is being explored as a treatment option in males infected with COVID-19.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33552835" target="_blank">33552835</a>
</td>
<td style="text-align:center;">
Such drugs comprise of inhibitors of Angiotensin-Converting Enzyme 2 (ACE2), transmembrane Serine Protease 2 (TMPRSS2), nonstructural protein 3C-like protease, nonstructural RNA-dependent RNA polymerase (RdRp) and many more.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33558541" target="_blank">33558541</a>
</td>
<td style="text-align:center;">
Among these drugs, a second-generation antiandrogen agent, enzalutamide, was proposed because it reduces the expression of transmembrane serine protease 2 (TMPRSS2), a key component mediating SARS-CoV-2-driven entry, in prostate cancer cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33558851" target="_blank">33558851</a>
</td>
<td style="text-align:center;">
Viral entry requires ACE2 and transmembrane protease serine 2 (TMPRSS2) for membrane fusion or through endosomal pathway.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33564221" target="_blank">33564221</a>
</td>
<td style="text-align:center;">
This is supported by prior work on related serine proteases suggesting further strategies to exploit in the design of more potent inhibitors.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33566370" target="_blank">33566370</a>
</td>
<td style="text-align:center;">
Likewise, these interventions had no effect on the expression of Transmembrane Protease Serine 2 (TMPRSS2) and Furin, proteases that facilitate the virus-cell fusion, and the expression or activity of Tumor Necrosis Factor α-Convertase (TACE) that cleaves cell-surface ACE2.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33571798" target="_blank">33571798</a>
</td>
<td style="text-align:center;">
Nefamostat, a FDA approved drug, well-known as a serine protease inhibitor for MERS-CoV infection, was used as the reference compound.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33577820" target="_blank">33577820</a>
</td>
<td style="text-align:center;">
Priming of S protein is done by serine 2 transmembrane protease and thus plays a key role in virus and host cell fusion.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33578831" target="_blank">33578831</a>
</td>
<td style="text-align:center;">
Previously, we had demonstrated the potential of natural compounds such as serine protease inhibitors eventually leading us to hypothesize that FDA-approved marine drugs have the potential to inhibit the biological activity of SARS-CoV-2 main protease.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="https://pubmed.ncbi.nlm.nih.gov/33578849" target="_blank">33578849</a>
</td>
<td style="text-align:center;">
Pharmacological NRF2 inducers have been reported to inhibit SARS-CoV-2 replication, the inflammatory response, and transmembrane protease serine 2 activation, which for the entry of SARS-CoV-2 into the host cells through the angiotensin converting enzyme 2 receptor.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33589624" target="_blank">33589624</a>
</td>
<td style="text-align:center;">
Our analysis highlights the importance of serine/threonine and tyrosine kinases as potential targets that intersect the SARS-CoV-2 and aging pathways.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33590936" target="_blank">33590936</a>
</td>
<td style="text-align:center;">
Several studies indicated that the genetic variants of the SARS-CoV-2 entry mechanism related (Angiotensin converting enzymes, Transmembrane serine protease-2, Furin) and host innate immune response related genes (Interferons, Interleukins, Toll like receptors); HLA, ABO, 3p21.31 and 9q34.2 loci are critical host determinants related to Covid-19 severity.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/33593260" target="_blank">33593260</a>
</td>
<td style="text-align:center;">
Breast cancer and COVID-19 share involvement of common comorbidities, hormonal signalling pathways, gender differences, rennin-angiotensin system (RAS), angiotensin-converting enzyme-2 (ACE-2), transmembrane protease serine 2 (TMPRSS2) and dipeptidyl peptidase-IV (DPP-IV).
</td>
</tr>
</tbody>
</table>
</div>

    </div>

    





















  </div>
</article>

      

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.js" integrity="sha256-yt2kYMy0w8AbtF89WXb2P1rfjcP/HTHLT7097U8Y5b8=" crossorigin="anonymous"></script>

      

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/highlight.min.js" integrity="sha256-eOgo0OtLL4cdq7RdwRUiGKLX9XsIJ7nGhWEKbohmVAQ=" crossorigin="anonymous"></script>
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/languages/r.min.js"></script>
        
      

    

    
    

    
    
    <script>const code_highlighting = true;</script>
    

    
    
    <script>const isSiteThemeDark = false;</script>
    

    
    
    
    
    
    
    <script>
      const search_config = {"indexURI":"/platcovid/index.json","minLength":1,"threshold":0.3};
      const i18n = {"no_results":"No results found","placeholder":"Search...","results":"results found"};
      const content_type = {
        'post': "Posts",
        'project': "Projects",
        'publication' : "Publications",
        'talk' : "Talks"
        };
    </script>
    

    
    

    
    
    <script id="search-hit-fuse-template" type="text/x-template">
      <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
      </div>
    </script>
    

    
    
    <script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js" integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js" integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin="anonymous"></script>
    

    
    

    
    

    
    
    <script id="dsq-count-scr" src="https://procovid19.disqus.com/count.js" async></script>
    

    
    
    
    
    
    
    
    
    
      
    
    
    
    
    <script src="/platcovid/js/academic.min.4aaf2d64e50f8e54cf66dcc54147a22e.js"></script>

    






  
  
  <div class="container">
    <footer class="site-footer">
  
  <p class="powered-by">
    
      
      <a href="/platcovid/supp/faq/">FAQ</a>
    
  </p>
  

  <p class="powered-by">
    BioHub - UFPE &middot; 

    Powered by the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

    
    <span class="float-right" aria-hidden="true">
      <a href="#" class="back-to-top">
        <span class="button_icon">
          <i class="fas fa-chevron-up fa-2x"></i>
        </span>
      </a>
    </span>
    
  </p>
</footer>

  </div>
  

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

</body>
</html>
